The Latin America, Middle East and Africa Colorectal Cancer Screening Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).
Improvements in genomics and molecular diagnostics have transformed the detection, diagnosis, and treatment of colorectal cancer. Genetic testing can assist in identifying high-risk individuals and guiding treatment decisions based on gene mutations. Non-invasive screening techniques, including liquid biopsy, provide less invasive and more easier screening options, increasing patient participation and promoting early detection.
Advancements in medical imaging and diagnostic technologies have improved the accuracy and effectiveness of colorectal cancer screening methods, encouraging more individuals to undergo screening. The development of newer and more accurate screening methods, such as non-invasive tests like fecal immunochemical tests (FIT) and blood-based tests, has made screening more convenient and accessible to a broader population.
Due to factors including increasing colorectal cancer incidence and more patient awareness in developing nations, there is an increase in demand. The current gold standard for diagnosing and screening colorectal cancer is colonoscopies. In addition, non-invasive tests have increased screening rates due to their cost-effectiveness, accessibility, and patient preferences. This pattern is anticipated to persist throughout the forecast period, fueling the demand.
Colorectal cancer rates in Latin America are influenced by a combination of factors, including changes in lifestyle, diet, aging populations, urbanization, and limited access to healthcare. As countries in Latin America experience urbanization and economic development, there is a shift towards more sedentary lifestyles and diets rich in processed foods, red meat, and sugary beverages. The region’s well established healthcare sector and the rising cancer cases are anticipated to contribute to the growth of regional market.
The Brazil market dominated the LAMEA Colorectal Cancer Screening Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $317.3 million by 2030. The Argentina market is estimated to grow at a CAGR of 9.1% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 8.3% during (2023 - 2030).
Based on Type, the market is segmented into Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), and Others. Based on End-user, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Colorectal Cancer Screening Market is Projected to reach USD 22.2 Billion by 2030, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Fecal Immunochemical Test (FIT)
- Fecal Occult Blood Test (FOBT)
- Stool-DNA Test
By End-user
- Hospitals & Clinics
- Clinical Laboratories
- Diagnostic Imaging Centres
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Novigenix SA
- Eiken Chemical Co., Ltd.
- Clinical Genomics Pathology, Inc.
- Exact Sciences Corporation
- Epigenomics AG
- BioMerieux S.A.
- Olympus Corporation
- Sysmex Corporation
- Fujifilm Holdings Corporation
- Siemens Healthineers AG (Siemens AG)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Colorectal Cancer Screening Market, by Type
1.4.2 LAMEA Colorectal Cancer Screening Market, by End-user
1.4.3 LAMEA Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. LAMEA Colorectal Cancer Screening Market by Type
5.1 LAMEA Colonoscopy Market by Country
5.2 LAMEA Stool-based Market by Country
5.3 LAMEA Colorectal Cancer Screening Market by Stool-based Type
5.3.1 LAMEA Fecal Immunochemical Test (FIT) Market by Country
5.3.2 LAMEA Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 LAMEA Stool-DNA Test Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Colorectal Cancer Screening Market by End-user
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Clinical Laboratories Market by Country
6.3 LAMEA Diagnostic Imaging Centres Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Colorectal Cancer Screening Market by Country
7.1 Brazil Colorectal Cancer Screening Market
7.1.1 Brazil Colorectal Cancer Screening Market by Type
7.1.1.1 Brazil Colorectal Cancer Screening Market by Stool-based Type
7.1.2 Brazil Colorectal Cancer Screening Market by End-user
7.2 Argentina Colorectal Cancer Screening Market
7.2.1 Argentina Colorectal Cancer Screening Market by Type
7.2.1.1 Argentina Colorectal Cancer Screening Market by Stool-based Type
7.2.2 Argentina Colorectal Cancer Screening Market by End-user
7.3 UAE Colorectal Cancer Screening Market
7.3.1 UAE Colorectal Cancer Screening Market by Type
7.3.1.1 UAE Colorectal Cancer Screening Market by Stool-based Type
7.3.2 UAE Colorectal Cancer Screening Market by End-user
7.4 Saudi Arabia Colorectal Cancer Screening Market
7.4.1 Saudi Arabia Colorectal Cancer Screening Market by Type
7.4.1.1 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Saudi Arabia Colorectal Cancer Screening Market by End-user
7.5 South Africa Colorectal Cancer Screening Market
7.5.1 South Africa Colorectal Cancer Screening Market by Type
7.5.1.1 South Africa Colorectal Cancer Screening Market by Stool-based Type
7.5.2 South Africa Colorectal Cancer Screening Market by End-user
7.6 Nigeria Colorectal Cancer Screening Market
7.6.1 Nigeria Colorectal Cancer Screening Market by Type
7.6.1.1 Nigeria Colorectal Cancer Screening Market by Stool-based Type
7.6.2 Nigeria Colorectal Cancer Screening Market by End-user
7.7 Rest of LAMEA Colorectal Cancer Screening Market
7.7.1 Rest of LAMEA Colorectal Cancer Screening Market by Type
7.7.1.1 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type
7.7.2 Rest of LAMEA Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis
TABLE 1 LAMEA Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Colorectal Cancer Screening Market
TABLE 4 Product Launches And Product Expansions– Colorectal Cancer Screening Market
TABLE 5 Acquisition and Mergers– Colorectal Cancer Screening Market
TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
TABLE 7 LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 8 LAMEA Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 9 LAMEA Colonoscopy Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Colonoscopy Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Stool-based Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Stool-based Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 14 LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 15 LAMEA Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Stool-DNA Test Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Stool-DNA Test Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 24 LAMEA Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 25 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 33 LAMEA Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
TABLE 35 Brazil Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 36 Brazil Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 37 Brazil Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 38 Brazil Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 39 Brazil Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 40 Brazil Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 41 Brazil Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 42 Brazil Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 43 Argentina Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 44 Argentina Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 45 Argentina Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 46 Argentina Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 47 Argentina Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 48 Argentina Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 49 Argentina Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 50 Argentina Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 51 UAE Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 52 UAE Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 53 UAE Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 54 UAE Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 55 UAE Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 56 UAE Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 57 UAE Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 58 UAE Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 65 Saudi Arabia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 67 South Africa Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 68 South Africa Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 69 South Africa Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 70 South Africa Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 71 South Africa Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 72 South Africa Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 73 South Africa Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 74 South Africa Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 75 Nigeria Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 76 Nigeria Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 77 Nigeria Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 78 Nigeria Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 79 Nigeria Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 80 Nigeria Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 81 Nigeria Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 82 Nigeria Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 89 Rest of LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 90 Rest of LAMEA Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 91 Key Information – Novigenix SA
TABLE 92 Key Information – Eiken Chemical Co., Ltd.
TABLE 93 Key Information – Clinical Genomics Pathology, Inc.
TABLE 94 Key Information – Exact Sciences Corporation
TABLE 95 Key Information – Epigenomics AG
TABLE 96 Key Information – BioMerieux S.A.
TABLE 97 Key Information – Olympus Corporation
TABLE 98 Key Information – Sysmex Corporation
TABLE 99 Key Information – Siemens Healthineers AG
TABLE 100 Key Information – Fujifilm Holdings Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Colorectal Cancer Screening Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors Colorectal Cancer Screening Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis – Colorectal Cancer Screening Market
FIG 8 LAMEA Colorectal Cancer Screening Market share by Type, 2022
FIG 9 LAMEA Colorectal Cancer Screening Market share by Type, 2030
FIG 10 LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2030, USD Million
FIG 11 LAMEA Colorectal Cancer Screening Market share by End-user, 2022
FIG 12 LAMEA Colorectal Cancer Screening Market share by End-user, 2030
FIG 13 LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2030, USD Million
FIG 14 LAMEA Colorectal Cancer Screening Market share by Country, 2022
FIG 15 LAMEA Colorectal Cancer Screening Market share by Country, 2030
FIG 16 LAMEA Colorectal Cancer Screening Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novigenix SA
FIG 18 SWOT Analysis: Clinical Genomics Pathology, Inc.
FIG 19 SWOT Analysis: Exact Sciences Corporation
FIG 20 SWOT Analysis: Epigenomics AG
FIG 21 SWOT Analysis: BioMerieux S.A.
FIG 22 Recent strategies and developments: Olympus Corporation
FIG 23 SWOT Analysis: Olympus Corporation
FIG 24 SWOT Analysis: Sysmex Corporation
FIG 25 SWOT Analysis: Siemens Healthineers AG
FIG 26 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 27 SWOT Analysis: Fujifilm Holdings Corporation